We (My Doctor, My Wife and I) decided to not do the additional year of the new Herceptin like pill that is new to the market.
Nerlynx (chemical name: neratinib) was approved by the U.S. Food and Drug Administration (FDA) on July 17, 2017 to treat early-stage, HER2-positive breast cancer for an extended period after surgery (doctors call this extended adjuvant therapy) in people who have previously been treated with Herceptin (chemical name: trastuzumab).
There seem to be some issues with its efficacy (it shows only a 2% improvement in one test and had a host of severe side effects). Some of you may want to do a bit of research online and consult with your Doctor about this new pill. It has been banned in much of Europe. Remember, I am not giving medical advice but am only telling you what I decided. Any decision on treatment should be between your Doctor, Your Family and Loved Ones and Yourself.